annual shareholders equity:
-$135.37M+$250.95M(+64.96%)Summary
- As of today (September 15, 2025), CYTK annual stockholders equity is -$135.37 million, with the most recent change of +$250.95 million (+64.96%) on December 31, 2024.
- During the last 3 years, CYTK annual shareholders equity has fallen by -$379.24 million (-155.51%).
- CYTK annual shareholders equity is now -155.51% below its all-time high of $243.86 million, reached on December 31, 2021.
Performance
CYTK Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
-$368.72M-$102.31M(-38.40%)Summary
- As of today (September 15, 2025), CYTK quarterly stockholders equity is -$368.72 million, with the most recent change of -$102.31 million (-38.40%) on June 30, 2025.
- Over the past year, CYTK quarterly shareholders equity has dropped by -$477.27 million (-439.68%).
- CYTK quarterly shareholders equity is now -248.07% below its all-time high of $249.02 million, reached on September 30, 2021.
Performance
CYTK quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CYTK Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.0% | -439.7% |
| 3 y3 years | -155.5% | -430.9% |
| 5 y5 years | -1137.7% | -372.2% |
CYTK Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -155.5% | +65.0% | -430.9% | +16.0% |
| 5 y | 5-year | -155.5% | +65.0% | -248.1% | +16.0% |
| alltime | all time | -155.5% | +65.0% | -248.1% | +16.0% |
CYTK Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$368.72M(+38.4%) |
| Mar 2025 | - | -$266.41M(+96.8%) |
| Dec 2024 | -$135.37M(-65.0%) | -$135.37M(+873.1%) |
| Sep 2024 | - | -$13.91M(-112.8%) |
| Jun 2024 | - | $108.55M(-127.4%) |
| Mar 2024 | - | -$396.16M(+2.5%) |
| Dec 2023 | -$386.32M(+258.0%) | -$386.32M(-12.0%) |
| Sep 2023 | - | -$438.80M(+31.7%) |
| Jun 2023 | - | -$333.12M(+45.5%) |
| Mar 2023 | - | -$229.02M(+112.3%) |
| Dec 2022 | -$107.90M(-144.2%) | -$107.90M(+575.3%) |
| Sep 2022 | - | -$15.98M(-114.3%) |
| Jun 2022 | - | $111.41M(-4.2%) |
| Mar 2022 | - | $116.26M(-52.3%) |
| Dec 2021 | $243.86M(+115.1%) | $243.86M(-2.1%) |
| Sep 2021 | - | $249.02M(+1410.2%) |
| Jun 2021 | - | $16.49M(-75.7%) |
| Mar 2021 | - | $67.85M(-40.2%) |
| Dec 2020 | $113.38M(-1136.7%) | $113.38M(-24.2%) |
| Sep 2020 | - | $149.60M(-291.6%) |
| Jun 2020 | - | -$78.08M(+70.8%) |
| Mar 2020 | - | -$45.71M(+317.9%) |
| Dec 2019 | -$10.94M(-142.2%) | -$10.94M(-45.0%) |
| Sep 2019 | - | -$19.87M(+305.8%) |
| Jun 2019 | - | -$4.90M(-245.2%) |
| Mar 2019 | - | $3.37M(-87.0%) |
| Dec 2018 | $25.93M(-76.4%) | $25.93M(-50.2%) |
| Sep 2018 | - | $52.07M(-30.7%) |
| Jun 2018 | - | $75.17M(-24.5%) |
| Mar 2018 | - | $99.60M(-9.3%) |
| Dec 2017 | $109.84M(+16.4%) | $109.84M(-25.3%) |
| Sep 2017 | - | $147.04M(-16.0%) |
| Jun 2017 | - | $175.00M(+83.5%) |
| Mar 2017 | - | $95.38M(+1.1%) |
| Dec 2016 | $94.36M(+37.6%) | $94.36M(+11.4%) |
| Sep 2016 | - | $84.72M(+73.8%) |
| Jun 2016 | - | $48.75M(-15.8%) |
| Mar 2016 | - | $57.91M(-15.6%) |
| Dec 2015 | $68.59M(-25.5%) | $68.59M(+1.9%) |
| Sep 2015 | - | $67.30M(-10.1%) |
| Jun 2015 | - | $74.86M(-11.0%) |
| Mar 2015 | - | $84.15M(-8.6%) |
| Dec 2014 | $92.06M | $92.06M(+25.0%) |
| Sep 2014 | - | $73.63M(-6.4%) |
| Jun 2014 | - | $78.70M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $86.18M(+58.3%) |
| Dec 2013 | $54.44M(-22.3%) | $54.44M(+37.0%) |
| Sep 2013 | - | $39.75M(-23.5%) |
| Jun 2013 | - | $51.99M(-11.0%) |
| Mar 2013 | - | $58.43M(-16.6%) |
| Dec 2012 | $70.08M(+45.5%) | $70.08M(-13.0%) |
| Sep 2012 | - | $80.60M(-10.4%) |
| Jun 2012 | - | $89.98M(+114.2%) |
| Mar 2012 | - | $42.01M(-12.8%) |
| Dec 2011 | $48.18M(-31.7%) | $48.18M(-15.1%) |
| Sep 2011 | - | $56.74M(-14.9%) |
| Jun 2011 | - | $66.65M(+11.9%) |
| Mar 2011 | - | $59.59M(-15.5%) |
| Dec 2010 | $70.52M(-30.5%) | $70.52M(-7.4%) |
| Sep 2010 | - | $76.12M(-12.8%) |
| Jun 2010 | - | $87.25M(-6.8%) |
| Mar 2010 | - | $93.64M(-7.7%) |
| Dec 2009 | $101.43M(+103.8%) | $101.43M(-9.7%) |
| Sep 2009 | - | $112.36M(-5.6%) |
| Jun 2009 | - | $119.06M(+152.3%) |
| Mar 2009 | - | $47.20M(-5.2%) |
| Dec 2008 | $49.77M(-50.2%) | $49.77M(-13.2%) |
| Sep 2008 | - | $57.30M(-21.1%) |
| Jun 2008 | - | $72.59M(-16.2%) |
| Mar 2008 | - | $86.62M(-13.3%) |
| Dec 2007 | $99.92M(-6.0%) | $99.92M(-8.8%) |
| Sep 2007 | - | $109.50M(-1.7%) |
| Jun 2007 | - | $111.34M(-8.7%) |
| Mar 2007 | - | $121.95M(+14.7%) |
| Dec 2006 | $106.31M(+44.5%) | $106.31M(+24.2%) |
| Sep 2006 | - | $85.59M(-7.8%) |
| Jun 2006 | - | $92.79M(-6.3%) |
| Mar 2006 | - | $99.05M(+34.7%) |
| Dec 2005 | $73.56M(-31.6%) | $73.56M(-6.0%) |
| Sep 2005 | - | $78.22M(-11.0%) |
| Jun 2005 | - | $87.86M(-9.9%) |
| Mar 2005 | - | $97.55M(-9.3%) |
| Dec 2004 | $107.56M(-17.1%) | $107.56M(-9.1%) |
| Sep 2004 | - | $118.37M(-7.5%) |
| Jun 2004 | - | $128.03M(+257.2%) |
| Mar 2004 | - | $35.84M(-138.9%) |
| Dec 2003 | $129.69M(+296.4%) | -$92.03M |
| Dec 2002 | $32.72M(-41.5%) | - |
| Dec 2001 | $55.95M(-2.9%) | - |
| Dec 2000 | $57.64M | - |
FAQ
- What is Cytokinetics, Incorporated annual stockholders equity?
- What is the all time high annual shareholders equity for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual shareholders equity year-on-year change?
- What is Cytokinetics, Incorporated quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly shareholders equity year-on-year change?
What is Cytokinetics, Incorporated annual stockholders equity?
The current annual shareholders equity of CYTK is -$135.37M
What is the all time high annual shareholders equity for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual stockholders equity is $243.86M
What is Cytokinetics, Incorporated annual shareholders equity year-on-year change?
Over the past year, CYTK annual stockholders equity has changed by +$250.95M (+64.96%)
What is Cytokinetics, Incorporated quarterly stockholders equity?
The current quarterly shareholders equity of CYTK is -$368.72M
What is the all time high quarterly shareholders equity for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly stockholders equity is $249.02M
What is Cytokinetics, Incorporated quarterly shareholders equity year-on-year change?
Over the past year, CYTK quarterly stockholders equity has changed by -$477.27M (-439.68%)